Evidence map›Paper›PMID 40430934›Full record

ArticlePharmaceutics2025

Novel Resolvin D1-Loaded Biologics as an Advanced Approach for Inflammation Control and Tissue Regeneration: Preparation and Characterization.

Zhe Xing, Jingwen Liang, Yang Sun, Jing Dai, Jiazheng Cai, Masahito Fujio, Yiwen Xu, Xiaoli An, Ying Xue

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Zhe XingSchool/Hospital of Stomatology, Lanzhou University, Lanzhou 730000, China.ORCID 0000-0002-7419-2012
Jingwen LiangSchool/Hospital of Stomatology, Lanzhou University, Lanzhou 730000, China.
Yang SunZhuoruan Medical Technologies (Suzhou) Co., Ltd., Suzhou 215434, China.
Jing DaiZhuoruan Medical Technologies (Suzhou) Co., Ltd., Suzhou 215434, China.
Jiazheng CaiDepartment of Medical Biology, Faculty of Health Sciences, UIT the Artic University of Norway, 9037 Tromso, Norway.ORCID 0009-0008-5148-1787
Masahito FujioDepartment of Oral and Maxillofacial Surgery, Nagoya University Graduate School of Medicine, Nagoya 464-0083, Japan.
Yiwen XuZhuoruan Medical Technologies (Suzhou) Co., Ltd., Suzhou 215434, China.
Xiaoli AnSchool/Hospital of Stomatology, Lanzhou University, Lanzhou 730000, China.
Ying XueDepartment of Clinical Dentistry, Faculty of Health Sciences, UIT the Artic University of Norway, 9037 Tromso, Norway.

Funding

Intelligent antibacterial material for oral medicine 071124013Open Subject Foundation of the Key Laboratory of Dental Maxillofacial Reconstruction and Bio-logical Intelligence Manufacturing 20JR10RA653ZDKF20210403
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biological matrixinflammation resolutionlyophilizationosteoblastic differentiationResolvin D1urinary bladder matrix

Identifiers

PMID40430934
PMCPMC12114963

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.